Literature DB >> 11355323

Strictureplasty for large bowel stenosis in Crohn's disease: quality of life after surgical therapy.

D C Broering1, C F Eisenberger, A Koch, C Bloechle, W T Knoefel, M Dürig, A Raedler, J R Izbicki.   

Abstract

The aim of surgical therapy in Crohn's disease is to improve quality of life. Surgery does not provide cure with radical resection of inflamed bowel. Therefore strictureplasty has become a useful bowel-preserving surgical technique in the treatment of small-bowel stenosis. To preserve functional bowel we extended the indication of this surgical technique to strictures in large bowel. The aim of this retrospective study was to define the efficacy of strictureplasty and resection in patients with obstructive Crohn's disease of the colon. The results were evaluated in terms of postoperative complications, surgical recurrence, and quality of life. The charts of 58 patients with Crohn's colitis were analyzed retrospectively. Patients were either treated by strictureplasty or resection. Quality of life was evaluated in follow-up examinations using the Inflammatory Bowel Disease Questionnaire. The incidence of postoperative surgical recurrence was 36% in those treated by strictureplasty and 24% in those treated by resection (ns). Postoperative morbidity was 16.1% in the former and 22.3% in the latter. There was no significant difference between the groups in quality of life measures (177 versus 182 points). Strictureplasty in Crohn's colitis is a valuable surgical technique which results in low recurrence rates and in surgical outcome comparable to that in resection without sacrificing functional large bowel length. In our study quality of life after strictureplasty was comparable with quality of life after resection.

Entities:  

Mesh:

Year:  2001        PMID: 11355323     DOI: 10.1007/s003840000278

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  9 in total

Review 1.  Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn's disease--review of the literature.

Authors:  Andreas G Wibmer; Anton J Kroesen; Jörn Gröne; Heinz-Johannes Buhr; Joerg-Peter Ritz
Journal:  Int J Colorectal Dis       Date:  2010-07-14       Impact factor: 2.571

2.  Crohn's disease or abdominal tuberculosis?

Authors: 
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

3.  European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Authors:  S P L Travis; E F Stange; M Lémann; T Oresland; Y Chowers; A Forbes; G D'Haens; G Kitis; A Cortot; C Prantera; P Marteau; J-F Colombel; P Gionchetti; Y Bouhnik; E Tiret; J Kroesen; M Starlinger; N J Mortensen
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 4.  Crohn's disease complicated by strictures: a systematic review.

Authors:  Florian Rieder; Ellen M Zimmermann; Feza H Remzi; William J Sandborn
Journal:  Gut       Date:  2013-04-26       Impact factor: 23.059

Review 5.  Multidisciplinary management of gastrointestinal fibrotic stenosis in Crohn's disease.

Authors:  Brice Malgras; Karine Pautrat; Xavier Dray; Pierre Pasquier; Patrice Valleur; Marc Pocard; Philippe Soyer
Journal:  Dig Dis Sci       Date:  2014-11-08       Impact factor: 3.199

6.  Efficacy and complications of surgery for Crohn's disease.

Authors:  Robert T Lewis; David J Maron
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-09

Review 7.  Strictureplasty in Complex Crohn's Disease: Beyond the Basics.

Authors:  Scott A Strong
Journal:  Clin Colon Rectal Surg       Date:  2019-07-12

8.  Clinical factors contributing to rapid reoperation for Crohn's disease patients undergoing resection and/or strictureplasty.

Authors:  David G Binion; Kenneth R Theriot; Sushrut Shidham; Sarah Lundeen; Ossama Hatoum; Hyun J Lim; Mary F Otterson
Journal:  J Gastrointest Surg       Date:  2007-12       Impact factor: 3.452

Review 9.  Indications and surgical options for small bowel, large bowel and perianal Crohn's disease.

Authors:  James Wt Toh; Peter Stewart; Matthew Jfx Rickard; Rupert Leong; Nelson Wang; Christopher J Young
Journal:  World J Gastroenterol       Date:  2016-10-28       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.